We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on August 21, 2014.
In connection with its proposed combination with AbbVie, Inc., Shire plc is publishing the audited consolidated financial statements of ViroPharma Incorporated and its subsidiaries as of December 31, 2013 and 2012 and for each of the years in the three-year period ended December 31, 2013. These audited consolidated financial statements are dated April 29, 2014.
The full text of this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/936402/000095010314005839/dp48769_8k.htm
Any exhibits and associated documents for this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/936402/000095010314005839/0000950103-14-005839-index.htm
Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Shire Chart |
1 Month Shire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions